APOLLO HOSPITALS ENTER. L vs SUVEN LIFE SCIENCES LTD

A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and SUVEN LIFE SCIENCES LTD (SUVEN) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, APOLLO HOSPITALS ENTER. L leads APOLLOHOSP vs SUVEN on 11 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation31
  • Profitability40
  • Growth10
  • Size & financial health31

Valuation

APOLLOHOSP takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

64.66
P/E ratio
-29.50
12.55
P/B ratio
13.30
0.23%
Dividend yield
0.00%
₹135.04
EPS
₹-10.48

Profitability

APOLLOHOSP takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

22.10%
Return on equity
-78.80%
18.00%
Return on capital
-77.00%
15.00%
EBITDA margin
-4001.00%
7.94%
Net margin
-3942.86%

Growth

APOLLOHOSP takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
-20.63%
33.39%
Profit CAGR (3Y) even

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.26L Cr
Market cap
₹10,090 Cr
₹25,228 Cr
Revenue
₹7 Cr
₹2,003 Cr
Net profit
₹-276 Cr
0.32
Debt / equity
0.01
APOLLO HOSPITALS ENTER. L
  • + ["Company has delivered good profit growth of 76.2% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
  • ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
SUVEN LIFE SCIENCES LTD
  • + ["Company is almost debt free."]
  • ["Stock is trading at 16.3 times its book value", "Company has low interest coverage ratio.", "Promoter holding has decreased over last quarter: -4.68%", "The company has delivered a poor sales growth of -12.0% over past five years.", "Company has a low return on equity of -65.9% over last 3 years.", "Debtor days have increased from 63.7 to 77.5 days.", "Working capital days have increased from 55.6 days to 506 days"]
APOLLO HOSPITALS ENTER. L full analysis SUVEN LIFE SCIENCES LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.